What is included in the long-term follow-up care for mantle cell lymphoma (MCL)?

Updated: Mar 15, 2019
  • Author: Muhammad Rashid Abbasi, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Usually, treatment and follow-up care of patients with MCL is performed in an outpatient setting. Follow-up may include the following:

  • Carefully monitor blood cell count prior to administering chemotherapy and 10-14 days after each treatment cycle.
  • Evaluate disease by monitoring history, physical examination findings, and imaging study results
  • Monitor adverse effects of chemotherapy by monitoring history, physical examination findings, and blood counts
  • Provide symptomatic treatment for adverse effects such as nausea, vomiting, diarrhea, mucositis, and fatigue
  • Provide psychosocial support

Admit patients for complications, disease progression, or adverse chemotherapy effects (eg, neutropenic fever or mucositis).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!